Advaxis Combination Trial with MedImmune Completes First Dose-Escalation Cohort
Mar 29, 2016 11:05 am UTC| Business
Study Commences Second Dose-Escalation Cohort 90-Patient Phase II Combination Trial in Cervical and Head and Neck Cancer to Begin Mid-Year PRINCETON, N.J., March 29, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical...
Mar 29, 2016 11:05 am UTC| Business
SAN RAMON, Calif., March 29, 2016 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet...
Mar 29, 2016 11:05 am UTC| Business
SAN CLEMENTE, Calif., March 29, 2016 -- CareTrust REIT, Inc. (Nasdaq:CTRE) announced the closing of its underwritten public offering of 8,500,000 shares of its common stock at a price to the public of $11.35 per share....
Gevo Announces Pricing of $3.5 Million Public Offering of Common Stock and Warrants
Mar 29, 2016 11:01 am UTC| Business
ENGLEWOOD, Colo., March 29, 2016 -- Gevo, Inc. (NASDAQ:GEVO), a leading renewable chemicals and next-generation biofuels company, announced today that it has priced its underwritten public offering of common stock and...
Mar 29, 2016 11:00 am UTC| Business
RedHill and its co-development partner, IntelGenx Corp., have entered into a binding term sheet with Grupo JUSTE granting an exclusive license to commercialize their acute migraine drug RIZAPORT™ in Spain, and a right of...
Mar 29, 2016 11:00 am UTC| Business
NEW YORK, March 29, 2016 -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage biotechnology company developing novel therapies for ophthalmic diseases, today announced that it has reached an agreement on the...
Tonix Pharmaceuticals to Present at the 10th Annual BIO Europe Spring Conference
Mar 29, 2016 11:00 am UTC| Business
NEW YORK, March 29, 2016 -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), which is developing next-generation medicines for fibromyalgia and post-traumatic stress disorder (PTSD), announced today that...